Dr. Connie Weaver Department of Nutrition Science Purdue University

Slides:



Advertisements
Similar presentations
Deriving Biological Inferences From Epidemiologic Studies.
Advertisements

Dr. Hala Hazam Al-Otaibi Department of Food Sciences and Nutrition, Community Nutrition College of Agriculture and Food Science, King Faisal University.
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
© Copyright 2011, Pearson Education, Inc. All rights reserved. Chapter 11 Caffeine.
Association of selected lifestyle factors with BMD Adjusted mean BMD* N HipSpine Whole Body __________________________________________________________________.
CONFERENCE ON “ FOOD ADDITIVES : SAFETY IN USE AND CONSUMER CONCERNS“ JOMO KENYATTA UNIVERSITY OF AGRICULTURE AND TECHNOLOGY NAIROBI, 24 JUNE 2014.
Nancy R. Cook, ScD Championing Public Health Nutrition November 25-26, 2014 Sodium and Cardiovascular Health.
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Critically Evaluating the Evidence: Tools for Appraisal Elizabeth A. Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant.
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Cadmium, environmental exposure, and health outcomes Ben Guo.
Interpreting Adverse Signals in Diabetes Drug Development Programs Featured Article: Clifford J. Bailey, Ph.D. Diabetes Care Volume 36: 1-9 July, 2013.
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
How much Calcium does your baby or child need per day? 0 to 6 months : 400mg 6 months to 1 year: 600mg Children 1-3 years: 500mg Children 4-8 years: 800mg.
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
Nutritional Analysis and Assessment
Pathogenesis of Osteoporotic Fracture LOW PEAK BONE MASS LOW PEAK BONE MASS POSTMENOPAUSAL BONE LOSS POSTMENOPAUSAL BONE LOSS AGE-RELATED BONE LOSS.
Estrogen plus Progestin, BMD and Fractures: Women’s Health Initiative Jane A. Cauley University of Pittsburgh JAMA 2003; 290 (13) :
Assessing dietary intakes in food environment research: Implications for policy and practice SHARON KIRKPATRICK University of Waterloo JILL REEDY, KEVIN.
Implications of the Current State of Scientific Knowledge David W K Acheson, M.D. Center for Food Safety and Applied Nutrition U.S. Food and Drug Administration.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
Bones Part 4 DR. T Jim, Tyler and Matt.
Anne Matthews, Health & Society, School of Nursing and Human Sciences, DCU The paradox of ‘low quality evidence; strong recommendation’: An analysis of.
Iron and Health The SACN Report Professor Peter J Aggett On behalf of SACN
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014.
OSTEOPOROSIS. Characteristics of osteoporosis include a reduction of bone density and a change in bone structure, both of which increase susceptibility.
Acute Toxicity Studies Single dose - rat, mouse (5/sex/dose), dog, monkey (1/sex/dose) 14 day observation In-life observations (body wt., food consumption,
CHANGES IN BONE MINERAL CONTENT AND BIOMARKERS OF BONE TURNOVER IN CHILDREN FED WITH MILK AIDA C. MALLILLIN Food and Nutrition Research Institute, Department.
Your Dietary Standards Common standards for evaluating nutrient intake –Dietary Reference Intakes –Dietary Guidelines for Americans –Regulations governing.
IADSA Scientific Forum 2009 The scientific substantiation of health claims David P. Richardson Scientific Adviser to UK Council for Responsible Nutrition.
Methodological quality assessment of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.
Andrew Mente, on behalf of the PURE investigators
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Cardiovascular.
Global Sodium Consumption and Death from Cardiovascular Causes Dariush Mozaffarian, M.D., Dr.P.H., Saman Fahimi, M.D., Gitanjali M. Singh, Ph.D., Renata.
Dr. Jennifer Peck University of Oklahoma Health Sciences Center
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Behavior Outcome.
Effectiveness of yoga for hypertension: Systematic review and meta-analysis Marshall Hagins, PT, PhD1, Rebecca States,
for Overall Prognosis Workshop Cochrane Colloquium, Seoul
Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder,
Dr. Daniele Wikoff – ToxStrategies Experimental Biology 2017
Nutrition for the Elderly
Normal bone architecture
Conflicts of interest Major role in development of GRADE
Factors Affecting Drug Activity
Milton Tenenbein, MD University of Manitoba
Donald E. Cutlip, MD Beth Israel Deaconess Medical Center
Supplementary Table 1. PRISMA checklist
Overview of the GRADE approach – selected slides
Impact of Antioxidant Beta-carotenoid on Lung and Colorectal Cancer Mortality: An 18 Year Follow-up Study of A National Cohort Daneisha Hawkins, BS; Dr.
HEALTH IN POLICIES TRAINING
Dr. Daniele Wikoff – ToxStrategies Experimental Biology 2017
Evidence-Based Medicine
Caffeine Consumption and its Affect on Bone Density Mass
Andrew Mente, on behalf of the PURE investigators
Lecture 4: Meta-analysis
AXIS critical Appraisal of cross sectional Studies
Insert Objective 1 Insert Objective 2 Insert Objective 3.
Calcium Deficiency.
GLOBAL DIETARY CALCIUM INTAKE AMONG ADULTS:
Research Rotation Part II
Dr. Daniele Wikoff – ToxStrategies Experimental Biology 2017
Lifestyle and related factors in older adults with osteoporosis
Protein for Healthy Bones
Critical Appraisal วิจารณญาณ
RESEARCH Effects of Medium-Chain Triglycerides on Weight Loss and Body Composition: A Meta-Analysis of Randomized Controlled Trials Karen Mumme, PGDipSc.
Level of Evidence Lecture 4.
Systematic Reviews and Meta-Analysis -Part 2-
Presentation transcript:

Dr. Connie Weaver Department of Nutrition Science Purdue University Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Bone and Calcium Outcome Dr. Connie Weaver Department of Nutrition Science Purdue University

Disclosure Member of the ILSI North America Caffeine Systematic Review Team Vice-Chair of ILSI Global Board of Trustees Science Advisory Board of Pharmavite Grant from Alliance of Potato Research and Education  

PECO Questions for the Bone and Calcium Outcome For [population], is caffeine intake above [dose], compared to intakes [dose] or less, associated with adverse effects on bone and calcium outcomes? Population Healthy Adults Pregnant Women Healthy Adolescents Children Exposure > 400 mg/day > 300 mg/day > 2.5 mg/kg-day Comparator ≤ 400 mg/day ≤ 300 mg/day ≤ 2.5 mg/kg-day Outcome Adverse effects on bone and calcium Example: For healthy adults, is caffeine intake above 400 mg/day, compared to intakes of 400 mg/day or less, associated with adverse effects on bone and calcium outcomes?

Caffeine

Characterization of Data for Bone and Calcium Outcome Data Type Characterization Number of studies 14 included; 26 excluded Study types All observational (cohort and cross-sectional); exception of 2 RCTs for calcium homeostasis Populations Adult (women/men; elderly; 1 study that included adolescents) Exposure Primarily dietary intake (e.g., food frequency questionnaires) – coffee, soda, tea, chocolate ~1/2 specifically evaluated caffeine Categorical groupings (e.g., <1 cup/day, >3 cups/day) Outcome (Endpoints) Risk of fracture (6) Bone mineral density (BMD) and osteoporosis (9) Calcium homeostasis (2)

Results: Risk of Fracture and Fall Discuss importance of calcium? Urinary calcium excretion is affected by calcium intake, so calcium intake needs to be considered in the analysis. Altered calcium balance through perturbing calcium excretion can influence bone mas The majority, although not all, of the data demonstrate a lack of effects of caffeine consumption at levels both above (up to 760 mg/day) and below 400 mg/day Effects <400 were of low magnitude (RR = <1.2) or were reported in analyses that did not consistently control for calcium intake Moderate confidence: findings generally consistent, most studies controlled for calcium intake

Results: BMD and Osteoporosis Discuss importance of calcium? Urinary calcium excretion is affected by calcium intake, so calcium intake needs to be considered in the analysis. Altered calcium balance through perturbing calcium excretion can influence bone mas The majority of studies support that the comparator of 400 mg/day in healthy adults is not harmful with respect to BMD and osteoporosis More evidence is needed for effects of caffeine intake between 200 and 400mg/day Effects <400 or >400 were associated with subgroups, single sites, and/or not associated with downstream events Moderate to low confidence: findings inconsistent, methods for controlling for calcium intake uncertain

Evaluation of Individual Study Quality (Risk of Bias) Overall “probably low” risk of bias across body of evidence Limited by exposure characterization (Q3, Q11) Consideration of calcium intake inconsistent (Q4) +2: Definitely low +1: Probably low -1: Probably high -2: Definitely high

Factors that increased or decreased confidence in the body of evidence by endpoint No. of Studies Initial Confidence Rating Based on study type and study features (OHAT, 2015) Overall RoB Domain-based evaluation of risk of bias per the OHAT RoB tool (OHAT, 2015) Indirectness Was the study designed to evaluate the PECO? Magnitude Strength of effect (when effect observed below the comparator) Confounding Were plausible confounders that would change the observed effect accounted for? Consistency Were findings consistent in demonstrating effects or lack of effects at or below the comparator Final Confidence Rating What is the overall rating when factors that increase or decrease confidence were considered Risk of fracture and fall 6 Moderate - ↓ ↓ / - ↑ / - BMD and osteoporosis 7 Moderate to low ↑ increased confidence - no change to confidence ↓ decreased confidence

Developing Conclusions for the Outcome: Integration of Weight of Evidence Considerations

WoE Conclusion: Bone and Calcium Outcome The comparator, 400 mg/day, was found to be an acceptable intake that is not associated with significant concern regarding overt, adverse effects on bone or calcium endpoints, particularly under conditions of adequate calcium intake. Some effects below the comparator; limited to physiological effects following acute exposure (altered calcium homeostasis) and subgroups in analyses of clinical endpoints (including those with low calcium intake) Effects generally low magnitude and/or were of overall low/negligible consequence to downstream events Several studies also reported on a lack of effect on the clinical endpoints following chronic consumption below the comparator, as well as above the comparator Moderate level of confidence evidence base Key limitations: inability to fully accommodate calcium intake, high level of indirectness, uncertainty in exposure estimates From manuscript: When the weight of evidence was considered, the comparator, 400 mg/day, was found to be an acceptable intake that is not associated with significant concern regarding overt, adverse effects on bone or calcium endpoints, particularly under conditions of adequate calcium intake. Although effects were observed at exposures below the comparator they were often limited to physiological effects following acute exposure (altered calcium homeostasis), and subgroups in analyses of clinical endpoints, including those with low calcium intake. Such effects were generally of low magnitude, and/or were of overall low/negligible consequence to downstream events. Several studies also reported on a lack of effect on the clinical endpoints following chronic consumption below the comparator, as well as above the comparator. Based on the underlying study type (11 observational, 2 RCTs, 1 meta-analysis) that constitute this evidence base, there is a moderate level of confidence in the research, which supports this conclusion. Key limitations that precluded a higher level of confidence were the inability to fully accommodate for calcium intake, the high level of indirectness, as well as an uncertainty in exposure estimates

Future Research Needs Non-adult populations Role of calcium Understanding physiology